FDA posts new technical guidance document outlining how sponsors should submit continuous glucose monitoring data collected during clinical trials for drugs and biologics.
Medical Devices
Boston Scientific Device Correction on Certain Pacemakers
Boston Scientific begins a Class 1 recall (device correction) involving certain pacemakers and cardiac resynchronization therapy pacemakers following reports of device malfunctions linked to four deaths.
